Press Releases

Jun 20, 2019 8:00am EDT

CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business

Jun 04, 2019 7:00am EDT

Clinical Results From CollPlant's Advanced Wound Care Product VergenixFG to Be Presented at European Wound Management Association Conference

May 30, 2019 7:00am EDT

CollPlant Reports First Quarter 2019 Financial Results and Provides Business Update

May 28, 2019 7:00am EDT

CollPlant Presents Its rhCollagen-based BioInks for 3D Bioprinting of Tissues and Organs at TERMIS Annual Meeting in Rhodes, Greece

May 22, 2019 8:41am EDT

CollPlant Launches New HQ and R&D Center in Israel

Apr 24, 2019 3:28pm EDT

CollPlant Announces Publication of Study in Science Translational Medicine Showing Composite Matrix Based on rhCollagen, Ceramics and Bone Morphogenic Protein Led to Bone Growth Superior to Standard of Care

Apr 23, 2019 7:00am EDT

CollPlant to Present at ThinkEquity Conference on May 2, 2019 in New York City

Apr 01, 2019 1:14pm EDT

CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update

Mar 18, 2019 8:00am EDT

CollPlant Renews Distribution Agreement for Its Soft Tissue Repair Product Vergenix™STR With Arthrex a World Leader in Orthopedics

Mar 11, 2019 7:00am EDT

Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks